Learn About Advances in Liver Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Advances in Liver Disease on CME Webcast. On this CME webcast, we’re going to hear about the latest chapter in the hepatitis C saga, that is, the treatment of hepatitis C. And we’re also going to hear about some of the other emerging liver diseases that you are likely to encounter in your clinical practice and some of the tools hepatologists use to evaluate liver conditions. Let me welcome today’s guests, both hepatologists from the Ohio State University. Dr. James Hanje is an Associate Professor of Internal Medicine and Dr. Anthony Michaels is also an Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Recognize the change in patient population in patients with chronic liver disease; Describe the problem of frailty; Review
methods of Hepatitis C diagnosis and staging; and Review current therapeutic Hepatitis C treatment options.

You’ll also learn about the following:

  • Causes of liver disease in the United States
  • Hepatitis C
  • The economics of treating hepatitis C
  • Transmission of hepatitis C

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Treatments for Brain Tumors

OSUWexnerbloglogo2014 New Treatments for Brain Tumors. Today, neurosurgeons can localize brain tumors to within millimeters of brain structures allowing today’s surgeons to use microsurgical techniques that many earlier surgeons could not have even dreamed of. On this CME webcast, we’re going to show you some of the techniques that now allow surgeons to operate on patients who 20 years ago would have been deemed inoperable. Joining our moderator, Dr. Jim Allen, in the studio is Dr. Brad Elder, an Associate Professor of Neurosurgery and the Director of neurosurgical oncology at the Ohio State University and Dr. Daniel Prevedello will be joining us by video. Dr. Prevedello is also an Associate Professor of Neurosurgery, and is the director of the minimally invasive cranial surgery program at Ohio State.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the new advances in the treatment of Brain tumors; and UNDERSTAND the treatment of Gliomas.

You’ll also learn about the following:

  • New neurosurgical approaches to brain tumors
  • Effect of histology on treatment of brain tumors
  • Current use of endoscopic and minimally invasive techniques in brain tumor surgery
  • Current use of robotics in brain tumor surgery

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education for Familial Heart Disease

OSUWexnerbloglogo2014 On-line Education for Familial Heart Disease. There are a lot more inherited heart diseases than anyone could have conceived of back in the 1970s. In the studio to provide an update on familial heart disease is cardiologist and professor of internal medicine as well as director of the OSU division of human genetics, Dr. Ray Hershberger. Also, joining us is genetic counselor and associate professor of internal medicine, Amy Sturm.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Describe the current state of genetic and genomic testing in cardiovascular medicine; and EXPLAIN the rationale, benefits, and limitations of cardiovascular genetics and genomics evaluation.

You’ll also learn about the following:

  • Family history in the era of electronic medical records
  • Advances in genetic testing
  • Whole genome sequencing
  • When to order genetic counseling
  • Clinical approach to the patient with a family history of sudden death
  • Clinical approach to the patient with a family history of CHF

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn Latest about Pancreatic Cancer

OSUWexnerbloglogo2014 Learn Latest about Pancreatic Cancer.  It seems as though about all physicians learned about the Whipple procedure in medical school and that is what most physicians associate with the surgical treatment of pancreatic cancer. But what has happened in the 80 years since Allen Whipple did his first pancreatic surgery? Well, we now understand pancreatic cancer much better and we have a rapidly expanding repertoire of surgical procedures that can be used in pancreatic cancer. On our CME Webcast today, to tell us about the current approach to pancreatic cancer, are two of Ohio State’s top experts in the disease. First, we have Dr. Peter Muscarella who is an Associate Professor of Surgery from the Division of General Surgery.  Also joining him is Dr. Mark Bloomston, an Associate Professor of Surgery from the Division of Surgical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the indications for curative resection for pancreatic cancer; to RECOGNIZE the role of new chemotherapy regimens in patients with advanced pancreatic cancer; to REVIEW the epidemiology and diagnostic evaluation of pancreatic cancer; and to DESCRIBE recent advances in staging and multimodality treatment for pancreatic cancer.

You’ll also learn about the following:

  • Why pancreatic cancer frequently presents in advanced stage
  • Current treatment options for pancreatic cancer
  • Screening for pancreatic cancer
  • Biopsy approaches
  • Weight loss, diet, and pancreatic cancer
  • The role of the primary care provider in follow up of pancreatic cancer
  • Advanced endoscopic techniques and pancreatic cancer
  • Histologic types of pancreatic cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast on Hearing Loss in Primary Care Identifies Causes

OSUWexnerbloglogo2014Webcast on Hearing Loss in Primary Care Identifies Causes.  On this MedNet21 webcast, we’re going to be discussing hearing loss: what causes it, how to evaluate it, and the newest technology to treat it including the newest advances in hearing aids. Here with our Moderator, Jim Allen, in the studio is Clinical Instructor in Otolaryngology from the Ohio State University, Dr. Aaron Moberly and OSU audiologist, Laura Feeney.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE conductive and sensorineural hearing loss and identify causes of these types of hearing loss; DESCRIBE different types of devices that can help patients with hearing loss.

You’ll also learn about the following:

  • Incidence of hearing loss
  • Initial steps in management of hearing loss
  • Tinnitus and hearing loss
  • Role of imaging studies in the evaluation of hearing loss
  • Cochlear implants
  • Hearing aids and WiFi connections
  • Hearing aids and HDMI connections
  • Medicare coverage for hearing aids
  • Drug-induced hearing loss
  • When to refer patients to the otolaryngologist
  • Heredity and hearing
  • Prevention of hearing loss

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.